TEDCO Generates $1 Billion in Economic Impact, 4,358 Jobs to Maryland Economy

The Maryland Technology Development Corporation’s (TEDCO) core research, technology transfer, and commercialization programs generated nearly $1 billion in economic contributions to the Maryland economy in 2015, according to a new study by the Battelle Technology Partnership Practice released today.

Battelle, the world’s largest non-profit research and development organization, also found that TEDCO’s efforts generated a total of 4,358 high-quality jobs, with an average income per job of $74,700. That compares favorably to a statewide average labor income per worker of $63,700.

Montgomery County DED Collaborates With TEDCO To Assist Life Sciences Startups

Montgomery County Department of Economic Development (DED) and Maryland Technology Development Corporation (TEDCO) are collaborating to assist Montgomery County life sciences companies to make progress toward commercialization.

With this collaboration, Montgomery County companies selected for TEDCO’s Life Sciences Investment Fund (LSIF) will become automatically eligible to receive a financial supplement of $25,000 from DED’s Life Sciences IMPACT Grant Program (LSIG).

TEDCO Awards Z-senz With First N-STEP Grant

The Maryland Technology Development Corporation (TEDCO) and National Institute of Standards and Technology (NIST) announced today that Z-senz LLC is awarded with the first NIST Science and Technology Entrepreneurship Program (N-STEP) grant. Z-senz, a Gaithersburg, MD-based company received $112,000 to develop resonant light detection and ranging (R-LIDAR) electronics for small unmanned aerial vehicles.


The Board of Directors of the Maryland Technology Development Corporation (TEDCO) has approved the Maryland Stem Cell Research Commission’s recommendation to fund 26 new research proposals totaling $8,406,269.

The newly-funded research projects show promise for contributing to cures for a wide range of debilitating diseases and conditions, including heart failure, stroke, multiple sclerosis, vascular diseases, Parkinson’s Disease, schizophrenia, autism spectrum disorders, and cancer.